Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Submitted by
admin
on August 18, 2015 - 9:26pm
Source:
Bizjournals.com
News Tags:
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
Headline:
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Do Not Allow Advertisers to Use My Personal information
